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Introduction
Most adults worldwide are infected with the human alphaherpesvirus varicella-zoster virus (VZV) (1). VZV 
causes varicella (chickenpox) as a primary infection, establishes a lifelong latent infection in ganglionic neu-
rons, and reactivates in one-third of  latently infected individuals to cause herpes zoster (shingles) (2). While 
primary VZV infection is generally benign in children, varicella is more severe and frequently accompanied 
by complications in adults and immunocompromised individuals (2). Pneumonia is the most common 
and serious complication of  chickenpox in adults, with an incidence of  1.0 to 2.3 cases per 400 varicella 
patients (3, 4). Furthermore, mild pneumonitis may be even more prevalent as radiographic abnormalities 
are detected in 16% of  adult varicella patients (5). Although prompt administration of  antivirals strongly 
reduces mortality rates, about 20% of  patients succumb to the disease due to secondary bacterial infections 
or acute respiratory distress syndrome (ARDS) (6).
The pathogenesis of varicella pneumonia is largely unknown, mainly because VZV is a human-restricted 
pathogen that does not cause disease in experimental animal models (7, 8) and due to the limited availability 
of clinical specimens from VZV pneumonia patients. VZV is transmitted via aerosols and presumably gains 
access to the body via infection of epithelial cells in the upper respiratory tract (9, 10). Although some virus 
may also reach the lower respiratory tract directly, VZV pneumonia typically develops after onset of skin rash 
about 2 weeks after infection (2, 11). Histological examination of affected lung tissue shows disseminated 
interstitial pneumonitis, focal hemorrhagic necrosis, fibrinous exudate in the alveolar spaces, and inflammatory 
cells in the alveolar wall and air sacs (11, 12). Notably, similar pathological findings are observed in nonhuman 
primates experimentally inoculated with simian varicella virus (SVV) (13, 14), the causative agent of varicella 
and herpes zoster in Old World monkeys (8). SVV and VZV genomes are colinear and share about 75% DNA 
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homology (15). More importantly, SVV infection of nonhuman primates recapitulates most if  not all patholog-
ical, virological, and immunological features of VZV infection in humans (8, 16–18).
There is an unmet need to determine the virus and host factors involved in the pathogenesis of  VZV 
pneumonia. Elucidation thereof  will potentially lead to the identification of  novel biomarkers that more 
accurately predict disease severity and guide the development of  more effective intervention strategies. In 
this study, we used the experimental SVV nonhuman primate model to unravel the cell types and mecha-
nisms involved in the pathogenesis of  varicella pneumonia.
Results
SVV infection causes fulminant varicella pneumonia. Fifteen juvenile cynomolgus macaques were intratracheally 
infected with SVV and euthanized at 3 (n = 5; group 1), 6 (n = 5; group 2), and 9 (n = 5; group 3) days postinfec-
tion (dpi) (Figure 1A). Five control animals were mock infected and euthanized at 3 dpi. SVV infection caused 
fever from 5 to 8 dpi (Figure 1B). Viral DNA was first detected in blood at 2 dpi (in 3 of 10 animals) and peaked 
at 5 dpi (Figure 1C). All SVV-infected animals became dyspneic after 6 dpi, indicative of varicella severe pneu-
monia. SVV DNA load in bronchoalveolar lavage (BAL) cells peaked at 4 dpi and declined slowly thereafter 
(Figure 1D). By contrast, recovery of infectious SVV peaked at 4 dpi and abruptly decreased after 5 dpi (Figure 
1E). SVV DNA loads in lung tissue were comparable with those in BAL cells (Figure 1F). Lungs of SVV-infected 
animals showed multifocal mild pulmonary consolidation with mild emphysema at 3 dpi. Lungs showed mod-
erate pulmonary consolidation at 6 dpi, which progressed to multifocal severe lung consolidation and hyperemia 
(likely interstitial pneumonia) with edema and emphysema at 9 dpi (Figure 1G). Edema was also observed in 
bronchi at 6 and 9 dpi. No aberrations were observed in control animals. Thus, intratracheal SVV infection of  
cynomolgus macaques leads to a brisk self-limiting virus replication in the lung, which was associated with clini-
cal signs and gross lung pathology that closely resembled VZV-induced pneumonia in humans (11, 12).
Varicella pneumonia is associated with severe histopathology in lung tissue. Primary bronchi of SVV-infected ani-
mals showed mild to moderate neutrophilic and lymphoplasmacytic inflammation within the epithelium of  
primary bronchi at 6 and 9 dpi (Figure 2, A and B). Foci of epithelial necrosis were present in primary bronchi 
of SVV-infected, but not in mock-infected, animals (Supplemental Figure 1, A and B; supplemental material 
available online with this article; https://doi.org/10.1172/jci.insight.138900DS1). SVV infection was associat-
ed with pronounced inflammation within bronchiolar walls, alveolar walls and alveolar lumen, and perivascular 
infiltrates (Figure 2, A and B). Bronchioles showed lymphoplasmacytic inflammation with focal hyperplasia 
of mucosal epithelium at 3 dpi, which progressed in severity at 6 dpi and 9 dpi (Figure 2, A and B). Lymphop-
lasmacytic inflammation, necrosis, fibrin deposition, and edema fluid were observed in alveoli of SVV-infected 
animals at 6 dpi. At 9 dpi, alveolar lumina showed severe lymphoplasmacytic inflammation, necrosis, hemor-
rhage, and fibrin deposition (Figure 2, A–C). Alveolar damage was associated with increase of type II pneumo-
cytes (Figure 2D), most likely representing tissue regeneration. Thus, intratracheal SVV infection of cynomolgus 
macaques leads to severe histopathology in the lower respiratory tract at 6 dpi — and especially at 9 dpi.
SVV replicates in epithelial cells and lymphocytes in lung tissue. Lung sections were analyzed for presence of  
SVV gene ORF63 RNA, one of  the most abundantly expressed viral transcripts during lytic infection (19), 
by in situ hybridization (ISH). SVV-infected cells were readily detected and widely disseminated through-
out the analyzed tissue sections at 3 dpi (Figure 2, E–G, and Supplemental Figure 1C). SVV predominantly 
infected alveolar epithelial cells (Figure 2E), in some animals associated with SVV-infected inflammatory 
cell infiltrates. To a lesser extent, SVV infected epithelial cells of  terminal bronchi and bronchioles, as well 
as cells within the bronchus-associated lymphoid tissue (BALT) (Figure 2, F and G). At 6 dpi, the number 
of  SVV-infected cells was lower compared with 3 dpi and more variable between animals. While occasional 
SVV-infected alveolar epithelial cells could be observed, SVV ORF63 transcription was predominantly 
observed in cells scattered throughout alveolar inflammatory cell infiltrates (Figure 2, H and I). Frequently, 
SVV-infected cells were localized in close proximity to blood vessels (Figure 2J), and occasionally virus- 
infected cells were detected in BALT. By contrast, SVV-infected cells were rarely detected in lung tissue of  
SVV-infected animals at 9 dpi. When present, SVV-infected cells localized adjacent to the vasculature (Fig-
ure 2K). Thus, consistent with quantitative PCR (qPCR) and virus isolation results (Figure 1), ISH analysis 
demonstrated that SVV replication in lung peaks early during infection.
Gene expression profiling in lung tissues from SVV-infected cynomolgus macaques. To investigate the mechanisms 
underlying the pathogenesis of  varicella pneumonia, we performed microarray gene expression profiling of  
lung tissues from mock- and SVV-infected animals (Supplemental Figure 2, A and B). Gene set enrichment 
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analysis was performed using the PANTHER enrichment test to identify statistically significant (FDR < 0.05) 
enriched Gene Ontology (GO) biological processes (20, 21). At 3 dpi, top enriched upregulated pathways in 
SVV-infected animals were mostly associated with innate antiviral immunity and cell cycle processes, while 
most significantly decreased pathways were related to neuron/cell development (Supplemental Figure 2C). At 
6 dpi, SVV-infected lungs were enriched for upregulated genes involved in both innate and adaptive (antiviral) 
immune responses and cellular responses to cytokines, with decreased expression of  genes involved in devel-
opmental processes (Supplemental Figure 2D). Most enriched upregulated pathways at 9 dpi were involved in 
cell cycle and proliferation, with lowered expression of  genes involved in developmental and morphogenesis 
Figure 1. SVV infection of cynomolgus macaques causes transient fever and fulminant pneumonia. (A) Experimental design. Time relative to mock or 
SVV infection (day 0) is indicated. Sampling time points and type are indicated by open (BAL) and closed (blood) inverted triangles. (B) Fluctuations in 
body temperature after mock (control) and SVV infection. Horizontal dashed lines, normal range in body temperature. Black solid line, mean. Gray filled 
area, 95% CI. Control, n = 5; SVV infection, n = 15 for 1–3 dpi, n = 10 for 4–6 dpi, and n = 5 for 7–9 dpi. (C, D, and F) SVV DNA qPCR on PBMC (C), BAL cells (D) 
and lung tissue (F). Data are expressed as SVV genomic DNA (gDNA) copies per 1 × 105 cells. (E) Infectious SVV titers in BAL cells. (C–F) Symbols indicate 
values of individual animals (group 1, filled square; group 2, open square; group 3, filled triangle); black horizontal line indicates median. (G) Photographs 
of lungs from control and SVV-infected animals. Arrows indicate lesions.
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processes (Supplemental Figure 2E). Overall, these analyses indicate that SVV infection resulted in a rapid 
induction of  innate antiviral responses in virus-infected lung tissue, followed by recruitment and activation of  
adaptive immune cells and, subsequently, a proliferative response potentially involving the increase of  adap-
tive immune cell populations and/or restoration of  lung parenchymal cells at 9 dpi.
SVV infection induces a robust innate antiviral immune response in lung tissue. The prototypic innate 
antiviral immune response is mediated by type I IFN (IFN-α/β) that inhibit virus replication and 
Figure 2. Histopathological changes and detection of SVV ORF63 RNA in lung tissue of SVV-infected cynomolgus macaques. (A–D) H&E-stained lung 
sections (A) were scored for inflammation (B), necrosis (C), and abundance of type II pneumocytes (D). *P < 0.05, **P < 0.01, ***P < 0.001 by 1-way ANOVA 
and Bonferroni’s correction. (A) Black arrowheads, inflammatory cells; white arrowheads, necrosis; asterisks, fibrin deposition; arrow, edema. Scale bar: 50 μm. 
(E–K) Lung sections stained for SVV ORF63 RNA by ISH (purple) and counterstained with hematoxylin (blue) at 3 dpi (E–G), 6 dpi (H–J), and 9 dpi (K). Enlarge-
ment of areas indicated by black boxes are shown. Scale bars: 50 μm (E and F, left panel), 100 μm (H–K), 200 μm (F [right panel] and G). Arrows, SVV RNA+ 
cells; asterisk, blood vessel; BALT, bronchus-associated lymphoid tissue.
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recruit inflammatory cells to the site of  infection (22). Gene expression analysis revealed that SVV 
infection resulted in a robust innate antiviral response dominated by IFN-α/β responses at 3 and 6 dpi 
(Figure 3A). Consistent with ISH and SVV DNA qPCR results (Figures 1E and Figure 2, E–G), SVV 
ORF63 transcript levels in lung tissue were highest at 3 dpi and steeply declined after 6 dpi (Figure 
3B). SVV replication in lung tissue was associated with increased expression of  IFNA2 mRNA (Figure 
3B), mainly produced by cells located in alveoli and infiltrating inflammatory cells (Supplemental 
Figure 3, A and B). Concordant with microarray results, expression of  IFN-stimulated genes (ISGs) 
MX1, IFIT1, DDX58, and STAT1 was increased at 3 dpi, peaked at 6 dpi, and returned to levels of  
mock-infected animals at 9 dpi (Figure 3B).
Figure 3. Innate immune responses in lung tissue of SVV-infected cynomolgus macaques. (A) Heatmap showing DEGs at 3 dpi involved in innate antiviral immu-
nity. Log2-fold change in gene expression is shown. Color gradient: blue, –3; white, 0; red, +6. (B) qPCR analysis of the indicated transcripts with data expressed as 
relative transcript level compared with GAPDH using the 2–ΔCt method. Horizontal line indicates mean. Red squares indicate undetectable. *P < 0.05, **P < 0.01 by 
1-way ANOVA and Bonferroni’s correction. (C–F) Consecutive lung sections stained for SVV ORF63 RNA (purple) by ISH and pSTAT1 (red) by IHC and counterstained 
with hematoxylin (blue) at 3 dpi (C and D) and 6 dpi (E and F). Enlargement of areas indicated by black boxes are shown. Scale bars: 200 μm.
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Upon activation of  the IFN-α/β receptor, STAT1 is phosphorylated and translocated to the nucle-
us, leading to transcription of  a broad panel of  ISGs (22). Therefore, we analyzed the in situ relation-
ship between virus-infected cells and IFN signaling by staining lung sections for SVV ORF63 RNA and 
phosphorylated STAT1 (pSTAT1). At 3 dpi, abundant pSTAT1 expression was observed in cells within 
SVV-infected BALT and occasional inflammatory cell infiltrates juxtaposed to SVV-infected alveolar 
cells (Figure 3C) — but not in alveolar epithelial cells (Figure 3D). By contrast, more widely distributed 
and abundant pSTAT1 expression was detected at 6 dpi within alveolar and bronchiolar epithelial cells, 
as well as inflammatory cell infiltrates located in alveoli and surrounding blood vessels (Figure 3, E 
and F). Overall, these findings demonstrate that SVV replication in the lung induced a robust IFN-α/β 
response and STAT1-mediated immune activation of  leukocytes in BALT and alveolar infiltrates.
Clearance of  SVV infection in lung tissue is associated with recruitment of  inflammatory cells. To further inves-
tigate the mechanisms underlying the inflammatory response in SVV-infected lungs, most notable after 
cessation of  virus replication, the profiles of  differentially expressed genes (DEGs) involved in cytokine 
and chemokine signaling were analyzed (Figure 4A). SVV infection strongly induced expression of  IFN-γ 
and several IL-6 family members (IL-6, leukemia inhibitory factor [LIF] and oncostatin-M [OSM]) in lung 
tissue. Chemokines most abundantly induced by SVV infection suggest chemotaxis of  neutrophils (CCL3, 
CXCL1, CXCL2, CXCL8, and SPP1), monocytes/macrophages (CCL2, CCL8, CCL13, CXCL10, CXCL12, 
CXCL17, and SPP1), and lymphocytes (CCL2, CCL5, CCL8, CCL13, CCL18, CCL20, CXCL10, CXCL11, 
and CXCL17) at 6 and 9 dpi (Figure 4A). Microarray results were confirmed by qPCR, showing that SVV 
infection significantly induced OSM, CXCL10, and IFNG mRNA levels at 6 dpi (Figure 4B).
Figure 4. Cytokines, chemokines, and immune cells in BAL and lung tissue of SVV-infected cynomolgus macaques. (A) Heatmap showing DEGs involved 
in cytokine and chemokine signaling. Log2-fold change in gene expression is shown. Color gradient: blue, –3; white, 0; red, +6. (B) qPCR analysis of the indi-
cated transcripts with data expressed as relative transcript level compared with GAPDH using the 2–ΔCt method. Horizontal line indicates mean values. (C 
and D) Graphs showing the extrapolated cell number (mean ± SEM) of BAL cell populations (C) and T cell populations (D), as determined by flow cytometry. 
CM, central memory; EM, effector memory. *P < 0.05, **P < 0.01, ***P < 0.001 by 1-way ANOVA and Bonferroni’s correction.
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To investigate the kinetics and cell types involved in varicella pneumonia, the phenotype and frequency 
of  cells in BAL samples were analyzed by ex vivo flow cytometry (Supplemental Figure 4, A and B). BAL 
cells of  mock-infected animals were mainly monocytes/macrophages (73% ± 14%; mean ± SD), with low-
er numbers of  granulocytes (14% ± 9%) and lymphocytes (13% ± 8%). SVV infection increased the total 
number of  leukocytes present in BAL samples, especially after 6 dpi (Supplemental Figure 4, C and D), and 
changed the cell types present in BAL. SVV infection was initially associated with an increase in granulo-
cytes and lymphocytes and a decrease in monocytes/macrophages. From 6 dpi onward, a marked increase 
in monocytes/macrophage and lymphocytes — and, to a lesser degree, granulocytes — was observed in 
BAL (Figure 4C and Supplemental Figure 4E). Although serial sampling may influence BAL cell compo-
sition, we did not observe any differences between BAL cells obtained at 2 dpi from group 1 (second BAL 
sample) and group 2 (first BAL sample). The BAL lymphocyte population of  mock-infected animals was 
mainly composed of  T cells (79% ± 11%) and NK cells (15% ± 9%) with fewer DCs (5% ± 4%) and B cells 
(<1%). SVV infection induced a swift increase in the number of  BAL DCs, followed by an increase in the 
NK cells and T cells (Figure 4C), initially central memory CD4+ and CD8+ T cells, followed by activated 
effector memory CD8+ T cells (Figure 4D and Supplemental Figures 4, F and G).
To determine the spatial distribution of  lung-infiltrating inflammatory cell types in SVV-infected ani-
mals, lung sections were stained for CD45 (leukocytes), neutrophil elastase (neutrophils), CD68 (mono-
cytes/macrophages), CD3 (T cells), granzyme B (grB; cytotoxic T cells and NK cells), and CD20 (B cells) 
by IHC. SVV infection caused increased CD45+ cell numbers in lung tissue, which colocalized with SVV-in-
fected cells at 3 and 6 dpi (Supplemental Figure 3C). Control animals had low numbers of  neutrophils and 
T cells in their alveolar septa and monocytes/macrophages in the alveolar lumen. The alveoli contained 
very low numbers of  grB+ cells and no B cells. SVV infection induced a mild increase in neutrophils, T cells, 
and grB+ cells at 3 dpi (Supplemental Figure 5A). Prominent inflammatory infiltrates composed of  neutro-
phils, T cells, monocytes/macrophages, and grB+ cells, but not B cells, were identified in alveoli at 6 dpi and 
further increased in numbers at 9 dpi (Supplemental Figure 5A). Simultaneously, SVV infection induced a 
robust expansion of  T cell and B cell populations in BALT (Supplemental Figure 5B). The combined flow 
cytometric and IHC analyses demonstrated that SVV infection resulted in the rapid mobilization of  innate 
immune cells — notably neutrophils, as well as DC and NK cells — to the lung, followed by a more abun-
dant influx of  neutrophils, monocytes/macrophages, and CD8+ T cells.
Next, we analyzed the location of cells expressing key chemokines potentially involved in recruitment of  
neutrophils (CXCL8), monocytes/macrophages (CCL2), and lymphocytes (CXCL10) in lungs of SVV-infected 
animals. SVV infection induced CXCL8 expression in bronchiolar epithelial cells and alveolar lining cells at 3 
dpi, followed by more abundant expression of CXCL10 by infiltrating inflammatory at 6 and 9 dpi (Figure 5A). 
Similarly, CCL2 and CXCL10 expression increased over time in the alveoli of SVV-infected animals (Figure 5, 
B and C). While CCL2 expression appeared to be restricted to inflammatory cells, CXCL10 was also abundant-
ly expressed by alveolar epithelial cells (Figure 5, B and C). Thus, the strong IFN-α/β response induced by 
SVV infection (Figure 3) led to expression of neutrophil-, monocyte/macrophage-, and lymphocyte-recruiting 
chemokines by lung-resident cells, which was further augmented by the infiltrating inflammatory cells.
Detection of  neutrophils and neutrophil extracellular traps in lung tissue of  SVV-infected cynomolgus macaques. 
Neutrophils are considered key players in the pathogenesis of  acute lung injury (ALI), in which accumula-
tion and activation of  neutrophils is associated with degranulation and release of  proteases, reactive oxy-
gen species, and proinflammatory cytokines (23, 24). Gene expression profiling of  lungs of  SVV-infected 
animals showed pronounced upregulation of  host genes involved in neutrophil chemotaxis (Figure 6A), 
consistent with the observed infiltration of  neutrophils in lungs of  SVV-infected animals (Figure 6B). More-
over, the contribution of  neutrophils in combatting pulmonary SVV infection is supported by upregulation 
of  genes involved in neutrophil degranulation (Supplemental Figure 7).
Recent studies implicate an important role for neutrophil extracellular traps (NETs) in ALI due to 
respiratory bacterial and viral infections (25–28). In response to proinflammatory cytokines, neutrophils 
can undergo a specialized form of  cell death, referred to as NETosis, leading to the release of  NETs com-
posed of  nuclear chromatin associated with histones and many granular antimicrobial proteins (29, 30). 
While NETs are considered to physically entrap and neutralize pathogens, excessive NET formation induc-
es alveolar lung damage (26). To analyze whether SVV and VZV can induce NETosis, human neutrophils 
were exposed to mock- and virus-infected cells. Both viruses significantly induced NET formation in vitro 
(Figure 6, C and D). Subsequently, lung sections from SVV-infected animals were stained for the NETosis 
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markers lytic granule component myeloperoxidase (MPO) and citrullinated histone H3 (citH3) (31, 32). 
SVV infection induced the deposition of  NETs at 6 and 9 dpi, as demonstrated by detection of  DNA mesh-
works associated with citH3 and MPO expression (Figure 6E). NETs were undetectable at 3 dpi and in 
control animals. To investigate the kinetics of  NET formation, serial BAL samples were analyzed for both 
cell-free histone-DNA (His-DNA) complexes, a commonly used surrogate marker for NETosis (33, 34), 
and MPO-DNA complexes, a specific marker for NETs (33, 35). His-DNA complexes were detected at low 
levels starting from 3 dpi, peaked at 6 dpi, and declined at later times after infection (Figure 6F). Previous 
studies suggested that His-DNA complexes in plasma correlate with NET formation in the lung (33, 36). 
Analyses of  paired plasma samples showed a similar profile of  His-DNA complexes, which peaked at 7 dpi 
and remained at the same level at 9 dpi (Figure 6F). The presence of  NETs was confirmed by detection of  
MPO-DNA complexes in a subset of  BAL and plasma samples (Figure 6G). Notably, MPO-DNA com-
plexes were detected in those animals with highest abundance of  His-DNA complexes in BAL and plasma. 
Collectively, these results suggest an important role for neutrophils and potentially NETosis in acute vari-
cella pneumonia of  SVV-infected cynomolgus macaques.
Detection of  NETs in BAL and plasma of  severe VZV pneumonia patients. To investigate the potential involve-
ment of  NETs in VZV pneumonia, we analyzed surplus BAL and paired (serial) plasma/serum samples, 
Figure 5. Expression of CCL2, CCL8 and CXCL10 transcripts in lung tissue of SVV-infected cynomolgus macaques. (A–C) Lung sections were stained for 
CXCL8 (A), CCL2 (B), and CXCL10 (C) transcripts by ISH (purple) and counterstained with hematoxylin (blue). Scale bars: 50 μm.
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Figure 6. Neutrophils and NETs in lung tissue of SVV-infected cynomolgus macaques. (A) Heatmap showing DEGs involved in neutrophil chemotaxis. Log2-fold 
change in gene expression is shown. Color gradient: blue, –3; white, 0; red, +6. (B) Lung sections stained for neutrophil elastase by IHC (red) and counterstained 
with hematoxylin (blue). Scale bar: 100 μm. (C and D) Human neutrophils were cocultured with medium (mock), PMA, uninfected or SVV-EGFP–infected (green) 
BS-C-1 cells, and uninfected or VZV-EGFP-infected (green) ARPE-19 cells for 6 hours. NETs were identified by staining for DNA (blue) and neutrophil elastase 
(red), followed by confocal microscopy (C) for quantification (D). (C) Representative images are shown (n = 2 donors, n = 3 replicates). Arrowheads indicate NETs. 
Scale bar: 20 μm. *P < 0.05 and **P < 0.01 by unpaired Student’s t test. (E) Lung sections stained for citrullinated histone H3 (citH3; green), MPO (red), and DNA 
(Hoechst-33342; blue). Scale bar: 20 μm. Arrowheads, NETs. Split channel images are shown for the area indicated by white boxes. (F and G) Detection of His-DNA 
(F) and MPO-DNA (G) complexes in BAL and plasma by ELISA. **P < 0.01 and ***P < 0.001 by 1-way ANOVA and Bonferroni’s correction. ULD, upper limit of 
detection. y axis indicates absorbance at 405–492 nm (F) and absorbance at 450–620 nm (G). (F and G) Red squares, BAL/plasma samples in which MPO-DNA 
complexes were detected (absorbance values greater than the maximum absorbance measured in control animals; indicated by dashed line).
1 0insight.jci.org   https://doi.org/10.1172/jci.insight.138900
R E S E A R C H  A R T I C L E
originally obtained for diagnostic purposes, from patients with severe varicella pneumonia (patients 1–3) 
and influenza pneumonia (patients 4–10) as controls (Supplemental Table 1). Involvement of  NETs in 
influenza pneumonia has recently been described (36). All paired BAL and plasma/serum samples of  
both the influenza pneumonia and VZV pneumonia patients contained His-DNA complexes (Figure 7A). 
MPO-DNA complexes were detected in all BAL samples from influenza pneumonia and VZV pneumonia 
patients (Figure 7B) but only in 2 of  6 available paired plasma/serum samples from influenza cases and 1 
of  3 paired plasma samples from VZV cases. Detection of  His-DNA and MPO-DNA complexes in blood 
correlated with disease severity in 1 VZV pneumonia patient (patient 1), with peak NET levels in plasma/
serum at 8 days after onset of  disease (corresponding to 1 day after admission to the hospital) and steady 
decline of  NET levels until hospital discharge at day 25 (Figure 7C). By contrast, MPO-DNA complexes 
were undetectable in plasma/serum samples obtained preceding and after NET+ BAL samples in patients 
2 and 3. Notably, NETs were detected in serum of  patient 3 shortly following secondary bacterial infection 
(S. aureus) (Figure 7C). Collectively, these findings indicate that NETs are present in BAL, but not necessar-
ily plasma/serum samples, from VZV pneumonia patients.
Mechanisms of  varicella pneumonia–associated ALI. ALI is associated with the influx of  protein-rich edema 
into the alveoli due to increased permeability of  the alveolar epithelial/endothelial-barrier (EEB) (23, 37). 
Combined fluorescent TUNEL assay and staining for epithelial marker cytokeratin indicated that epithelial 
cell death is not a major contributor to SVV-induced ALI (Supplemental Figure 6). Next, the expression 
profiles of  DEGs involved in epithelial and endothelial cell-cell junction and cell adhesion molecules in 
SVV- and mock-infected animals were analyzed (Figure 8A). Notably, SVV infection caused downregulation 
of  claudin-18 (CLDN18) and simultaneous upregulation of  CLDN2 and CLDN10. Claudin family members 
are essential for tight junction (TJ) formation and integrity, and they therefore regulate TJ permeability (38, 
39). Claudins are divided into 2 classes: sealing claudins (such as claudin-18) and pore-forming claudins (like 
claudin-2 and claudin-10) that prevent or promote paracellular flux, respectively (38). Additionally, gene 
expression analysis revealed decreased expression of  vascular endothelial cadherin (VE-cadherin, CDH5) 
(Figure 8A), an adherens junction protein that is essential for maintaining the endothelial barrier integrity in 
Figure 7. Detection of NETs in patients with severe varicella pneumonia and influenza pneumonia. (A and B) Detection of His-DNA (A) and MPO-DNA 
complexes (B) in paired BAL and blood samples (obtained ± 2 days of BAL sample) in human influenza and VZV pneumonia patients by ELISA. Squares 
and circles indicate plasma and serum samples, respectively. Dashed line indicates absorbance in serum of healthy human control subjects. (C) Correlation 
between His-DNA (circles) and MPO-DNA (squares) complexes in BAL (red), paired plasma/serum samples (light gray), and time from onset of disease 
in VZV pneumonia. Filled arrowhead indicates time of hospital discharge (patient 1); open arrowhead indicates time of death (patient 2); arrow indicates 
time of secondary bacterial infection of the lung (patient 3). (A–C) The y axis indicates absorbance at 450–620 nm.
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lung capillaries (40, 41). Microarray results were confirmed by qPCR, demonstrating that SVV infection sig-
nificantly induced CLDN2 and tended to increase CLDN10 expression, while simultaneously robustly down-
regulating CLDN18 and CDH5 expression in the lung (Figure 8B). Claudin-18 and VE-cadherin proteins 
were abundantly expressed in lungs of  mock-infected animals, which was significantly reduced upon SVV 
infection (Figure 8C), particularly at 6 and 9 dpi and in proximity to inflammatory infiltrates.
Finally, we analyzed whether neutrophil activation and/or NETosis may contribute to impaired EEB 
integrity in macaque lung tissue. Ex vivo lung slice cultures (Figure 9A) from 2 rhesus macaques were exposed 
to supernatant obtained from autologous neutrophil cultures treated with medium, PMA to induce NET for-
mation, or PMA and DNAse I to induce and subsequently degrade NETs. After 24 hours, CLDN18, CDH5, 
Figure 8. SVV infection affects expression of alveolar epithelial and endothelial cell junction proteins in SVV-infected cynomolgus macaques. (A) Heat-
map showing DEGs involved in cell adhesion, tight junctions, focal adhesions, and adherens junctions. Log2-fold change in gene expression is shown. Color 
gradient: blue, –3; white, 0; red, +6. Claudin-2 (CLDN2), CLDN10, CLDN18, and VE-cadherin (CDH5) are indicated in red. (B) qPCR analysis of the indicated 
transcripts and GAPDH. Data are expressed as fold change in gene expression relative to control animals (calibrator) and normalized to GAPDH using the 
2–ΔΔCt method. Horizontal line indicates mean. *P < 0.05 and **P < 0.01 by 1-way ANOVA and Bonferroni’s correction. (C) Lung sections stained for claudin-18 
or VE-cadherin (green). Nuclei were stained with Hoechst-33342 (blue). Scale bar: 20 μm.
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CLDN2, and GAPDH transcript levels were analyzed by qPCR, and claudin-18 and VE-cadherin protein expres-
sion was analyzed by IF staining. Claudin-18 transcript and protein levels were significantly reduced in lung 
slices incubated with supernatant from PMA-treated neutrophils (Figure 9, B and C), while DNase I treatment 
(partially) prevented claudin-18 downregulation. VE-cadherin transcript and protein levels were decreased in 
lung slices cultured with supernatant from PMA-treated or PMA + DNase I–cotreated neutrophils compared 
with mock-treated neutrophils (Figure 9, B and C). By contrast, none of the neutrophil supernatants affected 
CLDN2 expression (Figure, B and C). These findings indicate that NETs decreased CLDN18 expression, while 
other factors released by activated neutrophils caused downregulation of CDH5 transcription. Overall, our 
results indicate that impaired alveolar EEB integrity is a pathogenic feature of varicella pneumonia in SVV- 
infected cynomolgus macaques and suggest the role of neutrophils and NETs in this process.
Discussion
Varicella pneumonia is the most common and most severe complication of  primary VZV infection in adults, 
and its pathogenesis is largely unknown. The current treatment regimen — antiviral therapy and, when nec-
essary, supportive mechanical ventilation — still results in about 20% mortality and long-term impaired lung 
function (3, 42, 43). These data underscore the unmet need for novel intervention strategies that more effec-
tively treat varicella pneumonia. In this study, we have used the well-established SVV nonhuman primate 
model that closely mimics human VZV disease (7, 8) to determine the mechanisms underlying the patho-
genesis of  varicella pneumonia. We performed detailed functional genomics combined with virological, his-
topathological, and immunological analyses on paired BAL and lung tissues of  intratracheally SVV-infected 
cynomolgus macaques from 1 to 9 dpi. We report that SVV infection resulted in robust, transient virus rep-
lication that was controlled by innate antiviral immune responses in the infected lung. Additionally, the data 
Figure 9. Neutrophil activation and NETs affect expression of alveolar epithelial and endothelial cell junction proteins in ex vivo macaque lung slice cultures. 
(A) Diagram showing generation of macaque lung slice cultures. Lungs were resected (step 1), inflated with agarose (step 2), cooled, and manually cut (step 3) to 
generate ± 1 mm–thick slices that can be cultured for > 7 days (step 4). Figure adapted and modified from ref. 71. (B) qPCR analysis of the indicated transcripts 
and GAPDH on rhesus macaque lung slices cultured with supernatant of autologous neutrophils treated with medium (mock), PMA, or both PMA and DNAse 
I. Lung slices were obtained from 2 animals (open triangles and gray squares), with 2 replicates analyzed per animal. Data are expressed as fold change in gene 
expression relative to control animals (calibrator) and normalized to GAPDH using the 2–ΔΔCt method. Horizontal line indicates mean. *P < 0.05 by 1-way ANOVA 
and Bonferroni’s correction. (C) Lung slices were stained for claudin-18 or VE-cadherin (green). Nuclei were stained with Hoechst-33342 (blue). Scale bar: 20 μm.
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demonstrate that the host inflammatory response involving neutrophil activation and NET formation, rather 
than the direct cytopathic effect of  SVV, induced lung pathology that closely resembled varicella pneumonia 
in humans. We demonstrate that neutrophil activation directly affects expression of  claudin-18 and VE-cad-
herin in nonhuman primate lung slice cultures, hereby providing a potential mechanism that may contribute 
to impaired alveolar EEB integrity observed in varicella-induced ALI.
SVV replication in the lung was rapidly controlled by innate antiviral immune responses before the antic-
ipated impact of  an adaptive immune response. SVV infection induced profound IFN-α/β responses, most 
likely produced by alveolar macrophages and plasmacytoid DCs (44–46). Although SVV actively evades anti-
viral activity of  IFN-α/β in infected cells (47–49), secreted IFN-α/β induces ISGs in noninfected cells and 
stimulates the production of  chemokines/cytokines by respiratory epithelial cells and lung-resident inflam-
matory cells (22, 50). Moreover, we demonstrate that the attracted and activated immune cells perpetuated 
local chemokine production, thereby suggesting a multifaceted pulmonary immune response in which the 
initial recruitment of  neutrophils and NK cells — associated with the release of  lytic granules, NET forma-
tion, and IFN-γ production — coincides with control of  SVV replication. The subsequent influx of  a high 
number of  neutrophils, monocytes/macrophages, and T cells may further contribute to inhibition of  SVV 
infection and clearance of  virus-infected cells. However, robust SVV-specific T cell immunity does not appear 
until 10–14 dpi (46, 51), suggesting the limited role of  T cells in controlling primary SVV infection in the lung.
We provide the first evidence to our knowledge that NETs are formed in response to a pulmonary her-
pesvirus infection. NETs are released by neutrophils undergoing NETosis, which can be induced by reactive 
oxygen species, binding of  platelets to neutrophils, or recognition of  viral danger-associated molecular pat-
terns by pattern-recognition receptors expressed by neutrophils (52, 53). Virus-induced NET formation has 
been demonstrated for a broad range of  respiratory viruses, mainly RNA viruses including influenza A virus, 
respiratory syncytial virus, and rhinovirus (35, 54, 55). Entrapment of  viral particles or virus-infected cells 
by NETs restricts virus replication in vivo and in vitro (25, 52–55). Additionally, NETs may indirectly inhibit 
virus replication in vivo by activating immune cells (52, 53). Here, we showed that both SVV- and VZV-infect-
ed cells induce NET formation by human neutrophils, although the kinetics and abundance of  NET forma-
tion in SVV-infected cynomolgus macaques suggest their limited role in repressing virus replication.
Varicella pneumonia–induced ALI is associated with alveolar lymphoplasmacytic inflammation, 
edema, fibrin deposition, necrosis, hemorrhaging, and loss of  normal lung architecture of  SVV-infected 
monkeys. Similar pathological changes are induced by other (respiratory) viruses, also often after ces-
sation of  virus replication (36, 56), suggesting a prominent role of  local antiviral host responses rather 
than a direct SVV cytopathic effect on lung tissue. Indeed, we observed only small numbers of  apoptotic 
epithelial cells during the peak of  SVV infection. Impaired lung function results from extensive inflam-
mation, compromised alveolar EEB integrity, and accumulation of  edema and inflammatory cells in the 
alveolar lumen (24, 37). Here, we demonstrate that SVV infection was associated with downregulation 
of  endothelial adherens junction molecule VE-cadherin and epithelial sealing TJ molecule claudin-18 at 
the RNA and protein level, while simultaneously inducing RNA expression of  pore-forming claudin-2 
and claudin-10, most likely contributing to the observed impaired EEB integrity. Multiple RNA viruses 
and a variety of  inflammatory molecules and growth factors can downregulate VE-cadherin expression 
in endothelial cells (41, 57, 58), leading to alveolar edema formation and accumulation of  inflammatory 
cells (40). Previous studies demonstrated an important role for IL-6–induced upregulation of  claudin-2 
and IL-1β/TNF-α/IFN-γ–induced downregulation of  claudin-18 in increasing epithelial permeability 
(59, 60). Importantly, we demonstrate that neutrophil activation and NET formation were sufficient to 
decrease VE-cadherin and claudin-18 expression, respectively. Overall, the data indicate that inflamma-
tion — and especially neutrophils — contribute to ALI in varicella pneumonia.
Risk factors for developing life-threatening varicella pneumonia are incompletely understood. Smoking 
and pregnancy are associated with severe VZV pneumonia (61, 62). However, it remains challenging to predict 
the course of varicella pneumonia based on clinical signs at time of hospitalization (3, 43). Neutrophils and 
NETs play a central role in the pathogenesis of community acquired pneumonia (CAP) and its progression to 
ALI and ARDS (27, 63). High abundance of neutrophils and NETs in BAL samples of patients with both viral 
and nonviral CAP are associated with greater disease severity (27, 33, 36, 63, 64), and NET levels in paired 
plasma/serum samples are predictive for the clinical course of CAP (33). In line with these observations, 
we detected NETs in a subset of paired plasma and BAL samples during the course of self-limiting varicella 
pneumonia in SVV-infected animals. Consistent with prior studies, we observed NETs in BAL from influenza 
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pneumonia patients (36) and — for the first time to our knowledge — demonstrate their presence in BAL of  
varicella pneumonia patients. We did not observe a consistent correlation between NET levels in paired BAL 
and plasma samples, nor between NET abundance and disease outcome, in the 3 VZV pneumonia patients 
analyzed. However, given that our study was limited by the inclusion of a small number of severe varicella 
pneumonia patients, the potential use of NET abundance in BAL samples as a diagnostic marker for disease 
severity and prognosis needs to be further evaluated in a larger cohort of patients with VZV pneumonia.
In conclusion, we provide detailed insight into the virus and host factors involved in the acute phase 
of  varicella pneumonia. While antiviral therapy is critical to reduce varicella pneumonia mortality (65), 
our study suggests that the prognosis of  varicella pneumonia may be improved by simultaneously tar-
geting pulmonary immune responses. The benefit of  nonspecific immune suppression (corticosteroids) in 
varicella pneumonia patients remains controversial (6, 66). However, specific targeting of  potential patho-
genic innate immune cells involved in the pathogenesis of  ALI/ARDS, especially neutrophils, provides 
an exciting avenue to explore to reduce morbidity and mortality caused by varicella pneumonia. Notably, 
therapeutic inhibition of  NET production and inactivation of  NET components — such as recombinant 
human DNase I (Pulmozyme) used to treat cystic fibrosis patients (67) — are currently explored to improve 
the outcome of  pneumonia caused by other pathogens (26, 55, 68).
Methods
Cells and viruses. Low-passage WT SVV (Delta herpesvirus strain) and recombinant SVV-EGFP–expressing 
EGFP fused to the N-terminus of  ORF66 were cultured on BS-C-1 cells as described (18, 47) (Supplemen-
tal Methods). VZV-EGFP ectopically expresses EGFP and was cultured on ARPE-19 cells (47, 69).
Animal experiments. Twenty juvenile (2 years old) male SVV-seronegative cynomolgus macaques (Maca-
ca fascicularis), carrying i.p. implanted temperature transponders (Star-Oddi Ltd.), were intratracheally inoc-
ulated with 8.5 × 105 plaque forming units (PFU) of  SVV (n = 15) or an equivalent number of  uninfected 
BS-C-1 cells diluted in 5 mL of  PBS (n = 15) (Supplemental Methods). SVV-infected animals were euth-
anized at 3 dpi (n = 5; group 1), 6 dpi (n = 5; group 2), and 9 dpi (n = 5; group 3). Mock-infected animals 
were euthanized at 3 dpi (n = 5; group 4). Blood samples were collected at 0, 1, 2, and 3 dpi (groups 1 and 
4); at 0, 2, 4, and 6 dpi (group 2); and at 0, 3, 5, 7, 8, and 9 dpi (group 3). BAL was performed at 1, 2, and 
3 dpi (group 1); at 2, 4, and 6 dpi (group 2); at 5, 7, and 9 dpi (group 3); and at 3 dpi (group 4). Tissues 
collected at necropsy were formalin fixed and paraffin embedded (FFPE), snap-frozen in liquid nitrogen, or 
preserved in RNAlater solution (Thermo Fisher Scientific) and stored at –80°C.
Virus isolation and titration. BAL cells were incubated for 30 minutes at 37°C in 1 mL RPMI 1640 
(Thermo Fisher Scientific) containing 10% FBS (R10F) and 1 μg/mL Phytohemagglutinin-L (MilliporeSig-
ma), after which 10-fold serial dilutions of  BAL cells in R10F were added to semiconfluent BS-C-1 cells 
in 96-well plates (n = 8 replicates). After 7 days, infectious virus titers were calculated using the Spear-
man-Karber method and converted to PFU (PFU = 0.69 × TCID50).
Nucleic acid isolation and qPCR. DNA was extracted from PBMC, BAL samples, and frozen lung tissue 
using the QIAamp DNA Mini Kit (QIAGEN). RNA extraction was performed by homogenizing pooled 
frozen lung biopsies (n = 3 per animal) in 1 mL TRIzol reagent (Invitrogen) using the MP Fastprep-24 (MP 
Biomedicals) and the RNeasy Mini Kit (QIAGEN). cDNA synthesis was performed using 5 μg total RNA 
and Superscript IV reverse transcriptase (Invitrogen) with oligo(dT) primers (Invitrogen). qPCR was per-
formed in duplicate on an ABI Prism 7500 using TaqMan 2× Universal Master Mix (Applied Biosystems). 
DNA qPCR was performed with primers and probes specific for SVV ORF21 and the single copy gene OSM 
(70) (Supplemental Table 2). cDNA qPCR was performed with primers and probes specific for SVV ORF63 
(17) (Supplemental Table 2), OSM (70), CXCL10 (Mf02788358_g1) (47), CDH5 (Mf00901470_m1), CLDN2 
(Mf04369164_m1), CLDN10 (MF02862371_m1), CLDN18 (Mf02805373_m1), DDX58 (Mf02789247_m1), 
GAPDH (Mf04392546_g1), IFIT1 (Mf04355804_m1), IFN-α2 (Mf04256335_s1), IFN-γ (Mf02788577_m1), 
MX1 (Mf00895608_m1), and STAT1 (Hs01013996_m1) (Applied Biosystems).
RNA labeling and microarray analysis. Total RNA (200 ng) was labeled using the MessageAmp Pre-
mier RNA Amplification kit (Applied Biosystems) and hybridized to Rhesus Macaque genome–specif-
ic GeneChips (Affymetrix), according to the manufacturer’s recommendations. Image analysis was 
performed using GeneChip Operating Software (Affymetrix). Microarray data analysis is described in Sup-
plemental Methods. Raw data have been deposited in the ArrayExpress database under accession number 
E-MTAB-8485 (https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8485/).
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Flow cytometry. BAL cells were stained using fluorochrome-conjugated mouse monoclonal antibodies 
directed to human CD11b-PE (clone D12), CD45-PerCP (TU166), CD20–PE-Cy7 (L27), CD16-AF647 
(3G3), CD3–APC-Cy7 (SP34-2),CD8-AmCyan (SK1), CD95-PE (DX-2), CD69-PerCP (FN50), CCR4–
PE-Cy7 (1G1), CD28-APC (CD28.2), and CD4-V450 (L200) (All from BD Biosciences), as well as HLA-
DR–Pacific Blue (L243; BioLegend). Fluorescence was measured on a FACS Canto II and analyzed using 
BD FACS Diva software (both BD Biosciences) and FlowJo software (Tree Star Inc.) (Supplemental Meth-
ods, Supplemental Figure 4). Extrapolated cell number was determined for each of  the analyzed cell types 
present in BAL fluid as follows: “number of  BAL cells/mL” × “frequency of  the population.”
In situ analyses. FFPE tissue sections were analyzed by H&E staining, IHC, immunofluorescence (IF), and 
ISH. IHC and IF was performed using the following primary antibodies: mouse anti-CD3 (clone F7.2.38), 
anti-CD20 (L26), anti-CD68 (KP1), anti-granzyme B (GrB-7), anti–neutrophil elastase (NP57), anti–CD45 
(2B11 + PD7/26), and anti-CD31 (JC70A) (all from Dako); anti-cytokeratin (AE1/AE3) and anti-pSTAT1 
(Tyr701; clone ST1P-11A5) (Thermo Fisher Scientific); goat anti-MPO (AF3667; R&D systems); rabbit anti-
citH3 (ab5103), anti–claudin-18 (34H14L15), and anti–VE cadherin (ab33168) (Abcam); and anti–IFN-α 
(PBL Assay Science) as described in Supplemental Methods. ISH was performed using probes directed to 
SVV ORF63 (71), CCL2, CXCL8, CXCL10, ubiquitin C (positive control), and the bacterial gene dapB (negative 
control) using the RNAScope 2.5 HD Assay (Advanced Cell Diagnostics) (Supplemental Methods).
Pathology scoring. H&E-stained slides of  trachea, primary bronchus, and lung (n ≥ 2 lung samples per 
animal) were examined by experienced pathologists in a blinded fashion and scored the overall level of  
inflammation, necrosis, hemorrhage, fibrosis, emphysema, and the presence of  type II pneumocytes, on a 
scale from 0 to 3 (0, none; 1, mild; 2, moderate; 3, severe) (Supplemental Methods).
Neutrophils and quantification of  NET formation. Neutrophils were isolated from human and rhesus 
macaque blood by density gradient centrifugation using Polymorphprep (Axis-Shield). Neutrophils were 
cultured in RPMI 1640 supplemented with 2% FBS and antibiotics (R2F medium). To quantify in vitro 
NET formation, glass coverslips in 24-well plate wells were coated with poly-D lysine (50 μg/mL) for 2 
hours at 37°C, washed, and air-dried. Neutrophils were plated at 2 × 105 cells/well in 500 μL R2F, treated 
with PMA (500 nM; MilliporeSigma), or cocultured with either mock- and SVV-EGFP–infected BS-C-1 
cells or mock- and VZV-EGFP–infected ARPE-19 cells (2 × 105 cells/well) for 6 hours at 37°C. Neutro-
phils were fixed with 4% PFA dissolved in PBS, permeabilized using 0.1% Triton-X100 dissolved in PBS, 
and stained for DNA (Hoechst) and neutrophil elastase (clone NP57). Experiments were performed on 2 
human donors, and 3 biological replicates were analyzed. NETs were quantified by confocal microscopy.
Ex vivo lung slice cultures. Lungs from 2 rhesus macaques (Macaca mulatta; female, ages 10 and 16 years old), 
obtained from the Biomedical Primate Research Centre (Rijswijk, The Netherlands) were inflated with 4% 
low-melting 2-hydroxyethyl agarose (MilliporeSigma) dissolved in a 1:1 ratio of PBS and DMEM supplement-
ed with 10% heat-inactivated FBS (MilliporeSigma) and antibiotics (Lonza). Lung slices of approximately 1 
mm thick were manually cut (Figure 9A) and cultured in 6-well plate wells as described (72, 73). Neutrophils 
(8 × 106 in 8 mL R2F/well of a 6-well plate) were incubated with medium or PMA (500 nM; MilliporeSigma) 
for 6 hours. Some samples were additionally incubated with DNase I (2,000 units/mL; MilliporeSigma) for 
30 minutes. Supernatant of neutrophils treated with medium, PMA, or PMA and DNase was added to the ex 
vivo lung slices (1 mL supernatant added to 4 mL medium per well), and slices were cultured for an additional 
24 hours. Samples were stored in TRIzol for subsequent RNA extraction and qPCR analysis.
Detection of  His-DNA complexes. Clarified BAL supernatant (500g, 10 minutes) and plasma/serum samples 
were analyzed using the Human Cell Death Detection ELISAPLUS (MilliporeSigma). Cynomolgus macaque sam-
ples were analyzed using ABTS as a substrate and measured at 405 nm and 492 nm as a reference. Human 
samples were analyzed using 3,3’,5,5’-Tetramethylbenzidine (TMB) as a substrate and measured at 450 nm, using 
620 nm as a reference. For each species, all samples were analyzed in the same experiment and on the same plate.
Detection of  MPO-DNA complexes. BAL and plasma/serum samples were analyzed for the presence of  
MPO-DNA complexes as described (35). In brief, wells were coated with mouse anti-MPO antibody (5 μg/
mL; clone 4A4, Bio-Rad) overnight at 4°C. Samples (20 μL) were mixed with incubation buffer and perox-
idase-labeled anti-DNA antibody (80 μL/sample; both from the Human Cell Death Detection ELISAPLUS 
kit; MilliporeSigma), incubated for 2 hours at room temperature, and analyzed using TMB as a substrate. All 
analyzed macaque and human samples were measured on the same plate and in the same assay. Pooled plas-
ma from healthy human blood donors and supernatant of  PMA-treated human neutrophils were included as 
negative and positive control, respectively.
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Statistics. GraphPad Prism 5.0 (GraphPad Software Inc.) was used for statistical analyses. Data were 
analyzed using 1-way ANOVA corrected for multiple comparisons by Bonferroni’s adjustment (Figure 2, 
B–D; Figure 3B; Figure 4, B–D; Figure 6F; Figure 8B; Figure 9C; and Supplemental Figure 1, A and B) or 
unpaired 2-tailed Student’s t test (Figure 6D). P < 0.05 were considered significant.
Study approval. Surplus BAL, plasma, and serum samples from VZV and influenza pneumonia patients 
obtained for diagnostic purposes at the Erasmus MC (Rotterdam, the Netherlands) were used. Data col-
lection and analyses were conducted on anonymized samples, which was approved by the medical ethical 
committee of  the Erasmus MC (MEC-2015-306). Informed consent was waived by the institutional privacy 
knowledge officer. Animal experiments were performed in strict compliance with European guidelines (EU 
Directive on Animal Testing 2010/63/EU) and Dutch legislation (Experiments on Animals Act, 1997). 
The study protocol was approved by the independent animal experimentation ethical review committee 
Stichting Dier Experimenten Commissie Consult (DEC Consult, permit numbers EMC2975 [cynomolgus 
macaques] and BPRC permit number 7962 [rhesus macaques]). The manuscript text was written in accor-
dance with the Animal Research: reporting of  In Vivo Experiments (ARRIVE) guidelines.
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